These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 227345)

  • 1. The effect of pyrophosphate analogues on influenza virus RNA polymerase and influenza virus multiplication.
    Stridh S; Helgstrand E; Lannerö B; Misiorny A; Stening G; Oberg B
    Arch Virol; 1979; 61(3):245-50. PubMed ID: 227345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of the RNA polymerase activity of influenza virus A by pyrophosphate analogues.
    Cload PA; Hutchinson DW
    Nucleic Acids Res; 1983 Aug; 11(16):5621-8. PubMed ID: 6310507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the RNA polymerase activities from influenza virions and influenza virus-infected cells.
    Horisberger M; Guskey LE
    J Virol; 1974 Jan; 13(1):230-3. PubMed ID: 4811008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of diphosphonic analogues of inorganic pyrophosphate on activity of RNA-polymerases from the calf thymus].
    Komissarenko SV; Fomovskaia GN; Kolesnikova IN; Tarusova NB; Borisevich AN
    Ukr Biokhim Zh (1978); 1985; 57(2):56-62. PubMed ID: 2988169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thio-analogues of inorganic pyrophosphate inhibit the replication of influenza virus A in vitro.
    Hutchinson DW; Naylor M; Cullis PM
    Antiviral Res; 1985 Apr; 5(2):67-73. PubMed ID: 2990333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.
    Tomassini J; Selnick H; Davies ME; Armstrong ME; Baldwin J; Bourgeois M; Hastings J; Hazuda D; Lewis J; McClements W
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2827-37. PubMed ID: 7695269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus.
    Meneghesso S; Vanderlinden E; Stevaert A; McGuigan C; Balzarini J; Naesens L
    Antiviral Res; 2012 Apr; 94(1):35-43. PubMed ID: 22306172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-dependent RNA polymerase in nuclei of cells infected with influenza virus.
    Hastie ND; Mahy BW
    J Virol; 1973 Nov; 12(5):951-61. PubMed ID: 4358167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoionic heterocyclic compounds as candidate messenger RNA cap analogue inhibitors of the influenza virus RNA polymerase cap-binding activity.
    Mickleburgh I; Geng F; Tiley L
    Antivir Chem Chemother; 2009; 19(5):213-8. PubMed ID: 19483269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the particle-associated RNA-dependent RNA polymerase activity of influenza viruses by chelating agents.
    Oxford JS; Perrin DD
    J Gen Virol; 1974 Apr; 23(1):59-71. PubMed ID: 4833601
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of hepatitis B Dane particle DNA polymerase activity by pyrophosphate analogs.
    Nordenfelt E; Oberg B; Helgstrand E; Miller E
    Acta Pathol Microbiol Scand B; 1980 Jun; 88(3):169-75. PubMed ID: 6255741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphonoformate inhibits reverse transcriptase.
    Sundquist B; Oberg B
    J Gen Virol; 1979 Nov; 45(2):273-81. PubMed ID: 94344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral therapy targeting viral polymerase.
    Tsai CH; Lee PY; Stollar V; Li ML
    Curr Pharm Des; 2006; 12(11):1339-55. PubMed ID: 16611119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate, metal and template effects on inhibition of bacteriophage-qbeta ribonucleic acid polymerase by ortho- and pyro-phosphate.
    Brooks RR; Andersen JA
    Biochem J; 1978 Jun; 171(3):725-32. PubMed ID: 208514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the Interaction of Influenza Virus RNA Polymerase PA
    Dong LH; Cao XR
    Interdiscip Sci; 2018 Jun; 10(2):430-437. PubMed ID: 28631174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of T-705 against influenza virus.
    Furuta Y; Takahashi K; Kuno-Maekawa M; Sangawa H; Uehara S; Kozaki K; Nomura N; Egawa H; Shiraki K
    Antimicrob Agents Chemother; 2005 Mar; 49(3):981-6. PubMed ID: 15728892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza RNA transcriptase inhibitors: studies in vitro and in vivo.
    Oxford JS; Perrin DD
    Ann N Y Acad Sci; 1977 Mar; 284():613-23. PubMed ID: 280150
    [No Abstract]   [Full Text] [Related]  

  • 18. Influenza B virus: alpha-amanitin sensitivity of replication and primer-dependence of in vitro transcription.
    Mowshowitz SL; Deval J
    Arch Virol; 1980; 63(2):159-63. PubMed ID: 7356393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibitors of influenza virus replication as potential chemoprophylactic agents.
    Oxford JS
    J Antimicrob Chemother; 1975 Mar; 1(1):7-23. PubMed ID: 1100585
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase.
    Eriksson B; Larsson A; Helgstrand E; Johansson NG; Oberg B
    Biochim Biophys Acta; 1980 Mar; 607(1):53-64. PubMed ID: 6245699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.